Assessing the Safety and Tolerability of Conversion to Siponimod in Patients With Relapsing Forms of Multiple Sclerosis: Design of the EXCHANGE Study

Amit Bar-Or, Guy J Buckle, Stanley L Cohan, Bruce AC Cree, Yang Mao-Draayer, Micheline McCarthy, Aaron E Miller, Bianca Weinstock-Guttman, Robert J Fox, Nina Jaitly, Linda-Ali Cruz, Scott Kolodny, Xiangyi Meng, Davorka Tomic, Wendy Su

Consortium of Multiple Sclerosis Centers 2019

The presentation that you are looking for is no longer available on this site. Please contact Novartis Oncology Medical Information at 1-844-ONC-INFO (1-844-662-4636).